Nomad Power Solutions (NMAD) Market Capitalization (2010 - 2026)
Nomad Power Solutions (NMAD) posted Market Capitalization of $114.4 million for Q2 2026, up 410.3% on a QoQ basis from $22.4 million in Q4 2025, and up 4520.84% year-over-year from $2.5 million in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Market Capitalization (2010 - 2026) Analysis & Trends
Nomad Power Solutions has reported Market Capitalization for 17 years, with the latest figure at $114.4 million in Q2 2026.
- On a quarterly basis, Market Capitalization rose 4520.84% year-over-year to $114.4 million in Q2 2026; TTM through Jun 2026 was $114.4 million, a 4520.84% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, up 93.6% from the prior year.
- Market Capitalization was $114.4 million for Q2 2026 at Nomad Power Solutions, up from $22.4 million in the prior quarter.
- The five-year high for Market Capitalization was $169.1 million in Q1 2022, with the low at $2.5 million in Q2 2025.
- Average Market Capitalization over 5 years is $48.4 million, with a median of $9.8 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Market Capitalization slumped 94.5% in 2024, then jumped 4520.84% in 2026.
- Over 5 years, Market Capitalization stood at $84.9 million in 2022, then sank by 93.77% to $5.3 million in 2023, then declined by 13.62% to $4.6 million in 2024, then jumped by 390.96% to $22.4 million in 2025, then jumped by 410.3% to $114.4 million in 2026.
- The last three Market Capitalization figures came in at $114.4 million (Q2 2026), $22.4 million (Q4 2025), and $28.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.40 Mn |
| Dec 31, 2025 | 22.42 Mn |
| Sep 30, 2025 | 28.69 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 3.25 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 5.33 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 5.51 Mn |
| Jun 30, 2023 | 9.80 Mn |
| Mar 31, 2023 | 138.27 Mn |
| Dec 31, 2022 | 84.90 Mn |
| Sep 30, 2022 | 93.22 Mn |
| Jun 30, 2022 | 123.18 Mn |
| Mar 31, 2022 | 169.08 Mn |
| Dec 31, 2021 | 163.58 Mn |
| Sep 30, 2021 | 285.93 Mn |
| Jun 30, 2021 | 414.00 Mn |